Join the VCCC's distributed leadership team to enhance relationships across the alliance membership.
The Research & Education Lead for Gynae-Oncology (R&E Lead Gynae-Oncology) will champion the systemisation of collaboration across the VCCC Alliance and members to integrate cancer research, education and clinical care in the continuous improvement of patient outcomes.
With the ongoing objective of enhancing relationships across the VCCC Alliance, the position of Research & Education Lead for Gynae-Oncology is offered as an opportunity from within a VCCC Alliance member organisation to join our expert Distributed Leadership team.
The primary purpose for the appointment of the Research & Education Lead (R&E Lead) for Gynae-Oncology is to champion the systemisation of collaboration across the alliance and the broader cancer sector, to integrate cancer research, education and clinical care in the continuous improvement of patient outcomes.
Working with the guidance and support of the VCCC Alliance Executive Director, Professor Grant McArthur, the R&E Lead will provide leadership, strategic direction and expert advice for the research and education/training aspects of the gynae-oncology stream of the broader Distributed Leadership program, with the goal of embedding the latest research and evidence more quickly into routine clinical practice.
The R&E Lead will work closely with a program Steering Group and work together with a VCCC Alliance Program Manager and Head of Research to set goals that align with both organisational objectives and the aims of the Distributed Leadership program. With the support of a VCCC Alliance Program Manager, the R&E Lead, will also develop and implement actionable strategies and deliverables and report on deliverables.
- research and research-enabling infrastructure;
- education, training (including research training) and professional development;
- collection, linkage and sharing of health, clinical and research data that is an enabler
for research and research translation;
- availability of patient specimens and associated data as an enabler for research;
- systems and processes that promote multi-site clinical trials;
- facilitate consumer involvement in the development, implementation and
evaluation of the Program of Work to leverage valuable perspective and input;
- multi-disciplinary meetings as an enabler for professional development and research-led care;
- evidence for best practice across the continuum of care.
- increasing awareness of the role of the VCCC Alliance;
- identifying key opportunities for VCCC Alliance engagement;
- speaking publicly about VCCC Alliance programs in the media, scientific and clinical communities;
- contributing content to the VCCC Alliance newsletter and annual report as appropriate;
- other communication activities as and when appropriate.
- Identifying measures of success for their tumour stream or cross-cutting cancer theme;
- Key outcomes;
- Program sustainability measures;
- Program acceptability and reach.
Skills and Experience:
Qualifications:
The time commitment associated with this appointment will be variable, with the expectation that the R&E Lead will, with the support of their employer, agree how best to manage their R&E Lead responsibilities and their employment commitments.
Candidates should have availability to commit until 30 June 2024.
A set amount of funds will be provided periodically during the appointment to be used to support the successful incumbent in meeting their R&E Lead responsibilities, as best determined by the VCCC Alliance, the R&E Lead and their employer.
See further information about the VCCC Alliance distributed leadership team and download a copy of the position description.
For enquiries prior to applying for this role, please contact:
VCCC Alliance Head of Research, Dr Mark Buzza +61 3 8559 9061 [email protected] or
VCCC Alliance Executive Director, Professor Grant McArthur +61 3 8559 7063 [email protected]
Please send your CV and covering letter addressing the key selection criteria to Dr Mark Buzza at [email protected] no later than COB Friday 22 October 2021.